Genome engineering through homologous recombination (HR) is a powerful instrument for studying biological pathways or creating treatment options for genetic disorders. In mammalian cells HR is rare but the creation of targeted DNA double-strand breaks stimulates HR significantly.
INTRODUCTION
Manipulations to modify the genetic information of an organism have been applied to answer basic biological questions or to create treatment options for inherited disorders. Most of the current methods used in gene therapy protocols rely on random integration of a transgene. However, since gene expression is typically finetuned among tissues or during development and the cell cycle, random integration of a transgene under control of a heterologous promoter is a rather crude technique to alter the genome. Moreover, random integration can have genotoxic side effects by disrupting cellular genes or by misregulating expression of nearby genes, as recently shown in a gene therapy trial involving randomly integrating retroviral vectors [1] [2] [3] [4] .
Genetic manipulations that allow the precise replacement of one sequence with another can be accomplished through homologous recombination (HR). Unfortunately, HR is a rare event in mammalian cells, while random integration is much more frequent [5] . The creation of a targeted DNA double-strand break (DSB), however, has been shown to stimulate HR several hundredfold by activating the cellular machinery responsible for homology-directed repair [6] [7] [8] [9] . The repair of DSBs is crucial to the survival of mammalian cells and could therefore be a powerful tool to harness for genome engineering. By intentionally creating a DSB at a specific site in the genome, most recombination events can be directed to occur between the target locus and a DNA template that has been introduced into the cell. Nucleases that cleave DNA at prechosen sites to stimulate site-directed recombination (SDR) can be generated either by recombining existing homing endonucleases [10, 11] or by rational protein design. Chimeric nucleases that consist of a modified zinc-finger DNA-binding domain fused to the endonuclease domain of the FokI restriction enzyme have been shown to cleave DNA specifically in vitro and in vivo, although some cytotoxicity issues remain unresolved [12] [13] [14] [15] [16] [17] [18] .
In this paper, we engineer rationally designed zincfinger nucleases (ZFNs) and present a rapid method to evaluate them. The custom nucleases were generated by attaching the catalytic domain of FokI to a targetable DNA-binding domain, which was synthesized by assembling predefined C 2 H 2 -zinc-finger modules obtained by phage display [19, 20] . Each module is 28 amino acids in length and includes an a-helix that contacts 3 bases in the major groove of DNA. The modules can be assembled in the specific order necessary to recognize any given sequence in a target locus [19] [20] [21] . Because the FokI nuclease domain has to dimerize to become active [16] , two separate custom nucleases were generated. Each individual ZFN contains three zinc-finger modules recognizing a 9-bp binding site. The complete target sequence thus consists of two 9-bp binding sites in opposite orientation separated by a 6-bp spacer [15] . We have engineered novel custom nucleases and demonstrate that specificity of DNA-binding, expression kinetics, and protein design are crucial for a low level of cytotoxicity and a high frequency of SDR.
RESULTS

DNA-Binding Specificity
Affinity and specificity of DNA binding are crucial to the successful application of artificial nucleases in vivo. As proof-of-principle, we synthesized four novel DNA-binding domains that recognize four unrelated target sites (Fig.  1A) . To assess DNA binding separate from DNA cleavage, we fused the zinc-finger domains to the transcriptional activation domain of VP16 and evaluated them for their ability to activate expression of a reporter gene (Fig. 1B) . We performed assays in 293T cells using reporter constructs containing a single binding site for either GZF1 and GZF2 (1-2/Luc) or GZF3 and GZF4 (3-4/Luc) cloned upstream of a minimal promoter (Fig. 1C ). Although performed with plasmid DNA, the assay allows assessment of the specificity of DNA binding in the background of the human genome. Western blot analysis confirmed the steady-state levels of all zinc-finger transcription factors to be similar (Fig. 1D ), but only expression of AD-GZF1 and AD-GZF3 activated expression of luciferase significantly.
The control zinc-finger protein AD-ZF5C [22] did not stimulate luciferase expression from either reporter construct. These results imply that GZF1 and GZF3 encode highly specific DNA-binding domains, while specificity and/or affinity of GZF2 and GZF4 is not sufficient to mediate target recognition. This reporter assay thus provides a convenient way of quickly evaluating zincfinger-mediated binding to a specific DNA sequence.
Design and Expression Kinetics of Custom Nucleases
We then used custom nucleases based on the GZF3 DNAbinding domain to scrutinize design, expression kinetics, and cytotoxicity issues. Since the length of the amino acid linker between the zinc-finger domain and the catalytic FokI domain is critical for efficient cleavage of target DNA [13, 15] , we designed GZF3-based nucleases with linker lengths of either 21 (GZF3n-N) or 5 amino acids (GZF3-N and nGZF3-N). The presence and position of the nuclear localization signal are indicated by an bnQ in the name ( Fig. 2A) . As confirmed by indirect immunofluorescence, GZF3-N was distributed evenly throughout the cell, including the nucleus, while nGZF3-N and GZF3n-N were predominantly nuclear (data not shown). We determined expression levels of the nucleases in 293T cells 24 and 48 h after transfection (Fig. 2B) . The CMV promoter induced very high expression after 1 day, while expression from the cellular phosphoglycerate kinase (PGK) promoter and the herpes simplex virus thymidine kinase (HSV-tk) promoter was weaker. After 2 days, however, the patterns of nuclease expression were comparable. This suggests that high expression levels of the custom nucleases are not well tolerated by the cells, probably leading to their elimination over time through accumulation of nonspecific DSBs. The variability in the expression levels of the different GZF3 nucleases (compare GZF3-N with nGZF3-N) may be attributed mainly to differences in protein stability and/or cytotoxicity. To test whether overexpression of custom nucleases triggers apoptosis, we determined the number of apoptotic cells by measuring the DNA content of transfected 293T cells (Fig. 2C) . Expression of GZF3-N and nGZF3-N from a CMV promoter induced apoptosis in a significant number of cells, while expression of I-SceI, an intron-encoded endonuclease present in the mitochondria of yeast, or expression of the GZF3 nucleases from the weaker PGK and HSV-tk promoters, did not induce detectable levels of apoptosis.
Site-Directed Recombination in Episomal Gene Repair Assays
To determine quantitatively the stimulation of SDR by custom nucleases, we developed a plasmid-based gene repair assay that consists of three elements: a target plasmid, a repair plasmid, and the endonuclease (Fig. 3A) . The target plasmid contains a CMV-driven LacZ gene followed by stop codons and a 5V-truncated EGFP gene (BGFP). The stop codons and the 33-bp deletion ensure that no functional EGFP is expressed from the target plasmid [23] . We placed the 18-bp recognition site for ISceI alone (target plasmid b0-0Q) or in combination with binding sites for the ZFNs (e.g., two sites for GZF1 nuclease in target plasmid b1-1Q or two sites for GZF3 nuclease in target b3-3Q) between the two open reading frames. This way, each custom nuclease could be tested individually for its ability to stimulate SDR through insertion of a DSB into the target plasmid. The repair plasmid harbors a BLacZ-EGFP fusion gene and is designed to rescue EGFP expression through generation of a LacZ-EGFP fusion protein. To ensure that expression of LacZ-EGFP strictly depends on SDR, the repair plasmid does not contain a promoter and the LacZ gene is truncated at the 5V-end (BLacZ). An expression cassette for the red fluorescent protein DsRed-Express (REx) is located farther downstream to mark transfected cells.
To assess the effect of nuclease design and expression kinetics on SDR, we transfected 293T cells with target plasmid b3-3Q, the repair plasmid, and GZF3 nucleases. Fig. 3B shows the percentage of green cells normalized for transfection efficiency. In the absence of a nuclease 4% of cells turned green, while 36% of cells were green upon ISceI expression. Expression of GZF3-N and nGZF3-N from the CMV promoter induced cell death very efficiently, as indicated by the fact that the number of transfected cells dropped below 1% after 48 h. Due to the low numbers, we did not determine the frequency of gene repair. Conversely, expression of the same nucleases from the weaker PGK and HSV-tk promoters stimulated gene repair significantly and comparable to I-SceI. These results are in agreement with the apoptosis assay (Fig. 2C ) but point out that the apoptosis assay highly underestimated cytotoxicity induced by high levels of ZFNs. Expression of GZF3n-N from all promoters had no stimulatory effect on SDR, suggesting that long linkers decrease the efficiency of DNA cleavage [15] .
We validated specificity of the ZFNs by transfecting 293T cells with HSV-tk-driven nuclease expression vectors along with the repair plasmid and target plasmid b0-0Q or a target plasmid containing the respective binding sites (Fig. 3C) . Comparison of the repair frequencies revealed that GZF1-N and GZF3-N stimulated gene repair of targets b1-1Q and b3-3Q to an extent similar to that of I-SceI but had little effect on control plasmid b0-0Q. The overall stimulation of SDR by I-SceI, GZF1-N, and GZF3-N was between 10-and 15-fold. GZF2-N and GZF4-N did not significantly stimulate gene repair. These data are in line with the results of the reporter assay (Fig. 1C) , demonstrating that high affinity and specificity of target site recognition are crucial for stimulating SDR. 
Episomal and Chromosomal Gene Repair by Heterodimeric Custom Nucleases
We evaluated the efficiency of heterodimeric nucleases to promote SDR initially in the episomal gene repair assay (Fig. 4A) . Combined expression of GZF1-N and GZF3-N stimulated SDR to an extent similar to that of I-SceI, with almost 40% of transfected cells showing gene repair. Although some gene repair was measurable when GZF1-N or GZF3-N was expressed alone, stimulation of SDR was specific for target plasmid b3-1Q, as only background levels were detected with target b0-0Q. To assess whether the custom nucleases were able to promote gene repair in a chromosomal context, we generated a 293-based cell line. As opposed to the episomal gene repair assay, in which each cell probably contains about 1000 copies of the target plasmid, the 293/3-1 cell line contains a single integrated copy of target locus b3-1Q. Accordingly, we determined the number of EGFP-positive 293/3-1 cells 7 days after transfection as expression of LacZ-EGFP originated from a single bcorrectedQ gene (Fig. 4B) . In the absence of a nuclease, about 0.1% of cells underwent HR between the target locus and the repair plasmid. Expression of I-SceI stimulated SDR in a dose-dependent manner by a factor of 116 and 189, respectively, which is in good agreement with previously published results [7] [8] [9] 24, 25] . About 1% of transfected cells turned green upon expression of PGK-driven GZF1-N and GZF3-N. Transfections with higher amounts did not increase SDR and expression of a single custom nuclease had no stimulatory effect. Cytotoxicity induced by nuclease expression during chromosomal gene repair was estimated by analyzing the incorporation of propidium iodide (PI) of transfected 293/3-1 cells (Fig. 4C) . Compared to control or I-SceI, coexpression of GZF1N/GZF3-N from the PGK promoter did not affect cell survival, which is in good agreement with the apoptosis assay (Fig. 2C) .
Together, these data establish that custom nucleases can stimulate gene repair in episomal and chromosomal contexts. Moreover, the custom nucleases promoted replacement of up to 54 bp, indicating that this technology can be used to correct more than just point mutations.
DISCUSSION
Targeted manipulation of the genome through HR can be used to induce precise changes at specific locations in the genetic program of a living cell. Changing the genotype of a cell or organism will allow studies of gene function as well as treatments for patients suffering from inherited disorders. This report demonstrates that custom nucleases are a valuable tool for stimulating targeted manipulations of the genome. It also points out the ease and the difficulties of creating custom endonucleases. The two assays we present here allow a rapid evaluation of the DNA-binding specificity and a quick optimization of design and expression kinetics of the custom nucleases. Thus, using our simple two-step procedure, custom nucleases can be prescreened and optimized prior to their utilization in target cells.
Design of Custom Nucleases
Custom nucleases to stimulate SDR at a defined location can be chosen as follows. (i) Select a suitable target site. Thus far, zinc-finger modules recognizing GNN and ANN triplets have been identified by phage display [19, 20, 26] . Taking the 6-bp spacer between the two half-sites into consideration [15] , a full target site follows the sequence 5V-NNYVNNYVNNYVNNNVNNNVRNNVRNNVRNN (R = purine, Y = pyrimidine), which is statistically found every 64 bp in the human genome. The target site should be located as close as possible to the sequence to be replaced because the frequency of SDR drops steeply with increasing distance from the DSB [27] . To prevent continuous cleavage of the breplaced locus,Q at least one of the two ZFN binding sites should not remain after SDR. (ii) Assemble the custom DNA-binding domains. Our results show that not all DNA-binding domains assembled in this manner mediate specific binding to the target site. Since the neighbors influence the binding activity of an individual zinc-finger module, the use of alternative modules might improve specificity and affinity [21, 26] . Alternatively, the whole DNA-binding domain can be optimized through in vivo selection, as recently reported using a bacterial two-hybrid system [28] . (iii) Generate the reporter constructs and the custom transcription factors. The reporter assay allows one to preselect DNA-binding domains of high affinity and specificity. (iv) Generate the custom nucleases and the target plasmids and evaluate the custom nucleases in episomal gene repair assays individually or in combination as heterodimers. The choice of promoter is critical because high nuclease levels provoke the death of the target cells. The best combinations can then be employed in the final target cells. As shown here, preselected custom nucleases are expected to perform well in a chromosomal context.
Further Improvements and Outlook
The frequency of chromosomal SDR achieved here is in good agreement with results obtained in Drosophila [14] and Arabidopsis [29] , confirming that custom nucleases can perform well in complex genomes. Nonetheless, while stimulation of SDR by the custom nucleases in the episomal assay equaled the gene repair frequency measured with I-SceI, it was 10-fold lower for chromosomal gene repair. We assume that the lower frequency was at least partially due to cytotoxic side effects upon longterm expression of the nucleases, as previously suggested [17] . It will therefore be crucial to achieve a bburst-likeQ expression pattern, with high initial concentrations of the ZFNs that quickly drop after creation of the DSB. This could be achieved by mRNA transfer [30] or by use of inducible promoters [14] .
The full target sequence consists of 2 Â 9 bp. Every sequence encompassing a total of 18 bp defines a unique location in the human genome. However, the DNAbinding domains of the ZFNs recognize only the 9-bp half-site of the full target sequence. Statistically, a 9-bp sequence is found more than 10,000 times in the human genome. To compensate for this dilution effect more protein has to be expressed in the cell, which increases the probability of nuclease dimers being formed in the absence of DNA binding and hence the risk of unregulated cleavage of DNA. It would be interesting to see in a direct comparison whether four-finger proteins, which recognize a 12-bp half-site [18] , will ameliorate the problem by reducing the number of potential binding sites and increasing affinity and specificity.
The results shown here illustrate that custom nucleases facilitate the replacement of sequence stretches up to 54 bp. It remains to be determined whether even larger stretches of DNA can be substituted. This would offer treatment options for genetic diseases caused not only by point mutations but also by deletions and insertions.
Using ZFNs in combination with a repair template allows the correction of mutated genes in situ, thus presenting a novel and potentially safer form of gene therapy. Importantly, this technology can be easily combined with viral gene transfer systems. Vectors based on adeno-associated virus have proven to be particularly well suited to serve as templates for gene repair [24, 25, 31, 32] . Gene repair of human stem cells will be particularly intriguing [33] , as corrected cells could be expanded ex vivo and then reintroduced into patients. Our assay will provide a valuable tool for further optimizing the nucleases with regard to cytotoxicity, specificity, and design, so they can develop into routinely used genetic scissors.
MATERIAL AND METHODS
Plasmids and cell lines. DNA-binding proteins containing three zincfinger domains were assembled by overlap PCR and cloned into appropriate expression vectors using methods and domains described previously by Barbas and co-workers [19] [20] [21] 34, 35] . Briefly, overlapping PCR primers were designed to encode zinc-finger domains that had been obtained by phage display to bind unique 3-bp sites. Typically, zincfinger domains were chosen from those listed in Ref. [21] , although some variants were chosen from Ref. [34] . All plasmids were assembled by PCR and oligonucleotide-directed cloning. Relevant sequences are given in Figs. 1 and 3 . Complete sequence files can be obtained upon request. Briefly, the repair plasmids contain a 5V -deleted LacZ gene fused in-frame with a downstream EGFP open reading frame (Fig. 3A, top) . In the case of pUC.Zgfp/REx, an expression cassette for DsRed-Express (Clontech) to identify transfected cells is located farther downstream. Expression of a LacZ-EGFP fusion protein from the repair plasmids is prevented by an 1197-bp deletion at the 5Vend of LacZ and by omitting a promoter. LacZ-EGFP expression from target plasmids is prevented by a stop codon that terminates translation of LacZ and a 33-bp truncation at the 5Vend of the EGFP open reading frame [23] (Fig. 3A, bottom) . A binding site for I-SceI follows the stop codon in all target loci, while b1-1Q, b2-2Q, b3-3Q, b4-4Q, and b3-1Q contain additional bindings sites for the respective ZFNs, which have been introduced into the PacI site of b0-0Q (Fig. 3A, bottom) . All endonuclease expression plasmids are based on plasmid pRK5 [36] , in which the CMV promoter was substituted for the PGK or the HSV-tk promoter where indicated. The custom transcription factors were generated by cloning the zinc-finger domains into vector pRK5.AD [22] .
293 and 293T cells were grown in DMEM supplemented with 10% fetal calf serum. Cell line 293/3-1 was generated by transfecting 293 cells with target plasmid b3-1Q followed by selection in Geneticin (GibcoInvitrogen) at 400 Ag/ml. After clonal expansion, the presence of a singlecopy insertion was confirmed by Southern blot analysis (data not shown).
Reporter assays and immunoblotting. 293T cells in 35-mm wells were transfected in duplicate by calcium phosphate precipitation as previously described [22] . Transfection cocktails included 0.5 Ag of plasmids encoding the zinc-finger domains fused to the transcriptional activation domain of VP16, 1 Ag of the reporter plasmid, 0.1 Ag of pEGFP-N1 (Clontech), and 0.5 Ag of plasmid pCMVh (Clontech) expressing h-galactosidase to normalize for transfection efficiency. The amount of DNA was kept constant by adding pUC118 (ATCC 37462) to 4 Ag. Cells were harvested 40 h after transfection in PBS. Luciferase and h-galactosidase activities were measured in a luminometer (Berthold) using BrightGlo and BetaGlo substrates (Promega). Statistical significance was determined using the Student t test.
Immunoblotting was basically performed as previously described [36] . Briefly, 293T cells in 35-mm wells were transfected by calcium phosphate precipitation. Typically 2 Ag of the specific expression plasmid was used and pUC118 was added to 5 Ag. In the case of HSV-tk-containing plasmids 5 Ag was used. Cells were harvested 24 to 48 h after transfection. After resuspension in lysis buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.2% NP-40, 0.2% Triton X-100, 0.2% deoxycholate), equal amounts of proteins (50 Ag) were separated by SDS-polyacrylamide gel electrophoresis and transferred to Immobilon-P membrane (Millipore). Specific proteins were detected with a rabbit anti-HA tag antibody (Novus Biologicals, NB600-363) and visualized with Western Lightning chemiluminescence reagent (Perkin-Elmer).
Apoptosis and cell survival assay. To assess apoptosis, 293T cells in 12-well plates were transfected with 1.5 Ag of pEGFP-tubulin (obtained from Tony Hunter) and 0.5 Ag of nuclease expression vectors by calcium phosphate precipitation. Cells were harvested after 48 h in PBS, fixed for 1 h at 48C in 75% EtOH, washed with PBS, incubated in DNA extraction buffer (200 mM Na 2 HPO 4 , 100 mM citric acid, pH 7.8) for 5 min at room temperature, pelleted, resuspended in PI staining solution (3.8 mM Na citrate, 25 Ag/ml propidium iodide, 0.2 mg/ml RNase A, PBS) for 30 min at room temperature, and then analyzed by flow cytometry (FACSCalibur; BD Bioscience) to determine the sub-G1 population in EGFP-positive cells. Statistical significance was determined using the Student t test.
To assess cell survival, 293/3-1 cells in six-well plates were transfected with 0.5 Ag of pEGFP-C1 (Clontech) and 0.5 or 1.5 Ag of nuclease expression vector by calcium phosphate precipitation. The amount of DNA was kept constant by adding pUC118 to 4.5 Ag. Cells were harvested after 48 h in PBS/10% FCS and stained with PI, which is excluded by viable cells but penetrates cell membranes of dying or dead cells. After 30 min incubation at room temperature (final concentration 20 Ag PI/ml), 10 5 cells were analyzed by flow cytometry (FACSCalibur; BD Bioscience) to determine the percentage of EGFP-and PI-positive cells. Statistical significance was analyzed using the Student t test.
Gene repair assay. For episomal gene repair, 293T cells in 6-well plates were transfected by calcium phosphate precipitation with 50 ng of target plasmid, 2 Ag of repair plasmid pUC.Zgfp/REx or repair control pUC.REx, and 1 Ag of a nuclease expression vector, I-SceI (pRK5.LHA-Sce1) or control vector pCMV.Luc. The amount of DNA was kept constant by adding pUC118 to 4 Ag. After 2 days 10 5 cells were analyzed by flow cytometry to determine the percentage of EGFP-and REx-positive cells. For chromosomal gene repair, 293/3-1 cells in 12-well plates were transfected by calcium phosphate precipitation with 1.5 Ag of repair plasmid pUC.Zgfp or repair control pUC118, 0.75 Ag of a nuclease expression vector or control vector pCMV.Luc, and 5 ng of pDsRedExpress-N1 (Clontech). After 3 and 7 days 10 5 cells were analyzed by flow cytometry. The number of EGFP-positive cells at day 7 was normalized for transfection efficiency measured at day 3. Statistical significance of all assays was determined using the Student t test.
